CCL18, CCL22, CCL23, and CXCL12 consistently showed a negative correlation across most cancer types, while other anti-inflammatory chemokine genes displayed a more complex, context-dependent relationship, with both positive and negative correlations depending on the specific malignancy (Figure 4B). This evidence concerns the gene CCL22 and cancer.